A Phase I Study of CDX1307, hCG-B Vaccine, in Patients with Locally Advanced or Metastatic Breast Cancer, Colorectal, Pancreatic, Bladder and Ovarian Cancer.
http://www.clinicaltrials.gov/ct2/show/NCT00648102?
A Phase I Monoclonal IgG4 Antibody in Advanced or Recurrent Metastatic Castration-
Resistant Prostate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Malignant Melanoma
(MEL), and Non-Small Cell Lung Cancer (NSCLC).
http://www.clinicaltrials.gov/ct2/show/NCT00730639?
A Phase I Study of CDX1307, a Mannose-Receptor—Targeted hCG-B Vaccine, in
Patients with Incurable Breast, Colorectal, Porstate, Ovarian or Bladder Cancer
http://www.clinicaltrials.gov/ct2/show/NCT00709462? |
